| miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 | |
| Deng, Huixing; Geng, Qianqian; Ji, Ting; Yang, Aimin | |
| 刊名 | BIOMEDICINE & PHARMACOTHERAPY
 |
| 2018 | |
| 卷号 | 106页码:1072-1081 |
| 关键词 | miR-539 Chemoresistance Cisplatin Non-small celllung cancer DCLK1 |
| ISSN号 | 0753-3322 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2919021 |
| 专题 | 西安交通大学 |
| 推荐引用方式 GB/T 7714 | Deng, Huixing,Geng, Qianqian,Ji, Ting,et al. miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,106:1072-1081. |
| APA | Deng, Huixing,Geng, Qianqian,Ji, Ting,&Yang, Aimin.(2018).miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1.BIOMEDICINE & PHARMACOTHERAPY,106,1072-1081. |
| MLA | Deng, Huixing,et al."miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1".BIOMEDICINE & PHARMACOTHERAPY 106(2018):1072-1081. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论